Navigation Links
International Biotech Firm Funds Research Into Aging Through Foundation of UMDNJ
Date:3/16/2011

NEW BRUNSWICK, N.J., March 16, 2011 /PRNewswire-USNewswire/ -- Working with the Foundation of UMDNJ and New Jersey Health Foundation, Rostock Biotech Research Ltd, headquartered in Moscow, Russia, has donated $100,000 to fund the research of Dr. Alexey G. Ryazanov, a professor in the Department of Pharmacology at UMDNJ-Robert Wood Johnson Medical School (RWJMS) and a member of The Cancer Institute of New Jersey.  

The Blue Sky Research and Development Fund in Pharmacology in the Department of Pharmacology allows Dr. Ryazanov to investigate cellular and molecular mechanisms of aging and age-related diseases and to pursue research that would lead to better understanding of the fundamental principles of drug action.

"This funding permits Dr. Ryazanov to pursue cutting edge research without limitations on ideas or hypothesis," explained Dmitri Khan of Rostock Group, parent of Rostock Biotech Research. "We hope it will open the door for Dr. Ryazanov and his team to make unlimited discoveries that will have a positive impact in the future."

Working in concert with donors, the Foundation of UMDNJ/New Jersey Health Foundation can develop fund agreements that are individually tailored to meet donor needs.

"Because many of our donors wish to remain connected to the areas they help fund, this agreement, like many others we have developed, provides an opportunity for representatives from Rostock to meet with department representatives periodically to discuss innovative findings that might come about as a result of this research," explained George F. Heinrich, M.D., vice chair and CEO of the Foundation.  "It's very exciting for a researcher to be able to share his or her results with others who are passionate about their work."

To learn more about how you can fund research in an area that means the most to you, contact James M. Golubieski, Foundation president, at (908) 731-6601 or jgolubiesk
'/>"/>

SOURCE New Jersey Health Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Ranibizumab Market, ... by Novartis, ranibizumab was approved by CFDA to treat ... only Lucentis, a product of Novartis, is available in ... first self- developed drug for the treatment of wet ...
(Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015  Mylan ... its shareholders have approved Mylan,s proposed acquisition of ... and the related issuance of Mylan ordinary shares ... of shareholders held today. The transaction received the ... general meeting. In addition, the transaction received support ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
(Date:8/29/2015)... ... 30, 2015 , ... On September 30, 2015, the Career and Transfer Center ... accredited Maricopa Community Colleges , will be hosting a Job Expo to provide ... and opportunities. , The Expo has expanded to much more than just a typical ...
(Date:8/29/2015)... ... 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director ... Foundation) will present an educational program titled “Asbestos and Your Health.” , The two ... (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... to insufficient scrotal support and protection against dribbled urine and sweat. "In order ... Manhasset Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal ...
(Date:8/29/2015)... CA (PRWEB) , ... August 29, 2015 , ... Dr. ... a mission. His mission is to increase acceptance of the chiropractic field in ... medications that further debilitate them. Although Chiropractic was made available to the VA ...
(Date:8/29/2015)... NY (PRWEB) , ... August 29, 2015 , ... Next ... end of summer (which astronomically, officially ends on September 22nd this year). For IT ... cyber security hangovers linger on which could prove far more costly than a simple ...
Breaking Medicine News(10 mins):Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
... ... FEHBP oppose a new effort by Congress to reduce pharmacy choices, arbitrarily ... in the program. FEHBP enrollees feel that OPM does a great ... than help the program by forcing OPM to change FEHBP’s pharmacy benefits. ...
... with operable disease, review finds , WEDNESDAY, March 24 ... operable non-small cell lung cancer, say researchers who reviewed ... studies involving almost 8,500 patients (and more than 3,300 ... percent for patients who had chemotherapy and surgery, and ...
... Obama signed into law U.S. health care reform legislation, ... their families, and businesses. The national health ... in Massachusetts requiring all adults in the Commonwealth to ... new article from The Milbank Quarterly , by ...
... University in Silicon Valley will host a one-day workshop ... focus on the role of high-tech communication and other ... plan to identify mutually beneficial research agendas and exchange ... campus," said Martin Griss, director of Carnegie Mellon,s Silicon ...
... damage to a neural center for emotions don,t get ... 24 (HealthDay News) -- Your ability to judge wrongdoing ... based in a part of the brain that regulates ... Institute of Technology report that people who suffer from ...
... come loaded with vitamin E, to help more medicine get ... -- A team of researchers has created special contact lenses ... a design that could essentially lengthen the amount of time ... reduce the significant waste of medication that happens with traditional ...
Cached Medicine News:Health News:PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP 2Health News:Chemo May Boost Survival After Lung Cancer Surgery 2Health News:Massachusetts health care reform reviewed as a model for national plan 2Health News:Brain's 'Moral Outrage' Center Pinpointed 2Health News:New Contact Lenses Could Improve Glaucoma Treatment 2Health News:New Contact Lenses Could Improve Glaucoma Treatment 3
...
...
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium....
Solid 13.5 mm wide by 5 mm deep blades. Edge of blades serrated. Dull finish....
Medicine Products: